Atrial, ventricular, and plasma atrial natriuretic factor during the evolution of congestive heart failure
Mark A. Perrella(Brigham and Women's Hospital), John C. Burnett(Mayo Clinic in Arizona), Brian O’Murchu, Thomas R. Schwab, Brooks S. Edwards(Mayo Clinic)
Cited by 1
Related Papers
Valvular Heart Disease Associated with Fenfluramine–Phentermine
|New England Journal of Medicine|1997|1.6k
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710
Endothelin in human congestive heart failure.
|Circulation|1994|588